Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep27 | Adrenal and Cardiovascular Endocrinology | ECE2023

Metanephrines work-up in patients diagnosed with incindentaloma - the influence of commonly used drugs on results interpretation

Kokoszka Joanna , Opalinska Marta , Kolasa Magdalena , Szewczyk Monika , Sitarz Katarzyna , Bugajska Jolanta , Berska Joanna , Sztefko Krystyna , Hubalewska-Dydejczyk Alicja

Introduction: Due to the frequent occurrence of adrenal incidentalomas, diagnosis of their hormonal activity is a significant clinical concern. Approximately 7-10% of adrenal tumors are pheochromocytomas, which even in silent form can lead to hemodynamic instability during surgery. According to the ESE and ENSAT guidelines in any case of adrenal tumors greater than 1 cm pheochromocytoma should be excluded based on plasma metanephrines level and urinary metanephrines excretion....

ea0099p113 | Pituitary and Neuroendocrinology | ECE2024

2-[18F]FDG PET imaging biomarkers for clinical and metabolic assessment in ectopic cushing syndrome. increased spleen FDG uptake as a helpful parameter to predict the presence of metastases - a pilot study

Rzepka Ewelina , Kokoszka Joanna , Opalinska Marta , Sitarz Katarzyna , Grochowska Anna , Sowa-Staszczak Anna , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: 2-[18F]FDG PET/CT, commonly used for neoplastic lesions detection, also allows assessment of the severity of the inflammatory processes. Moreover, glucose uptake in spleen and bone marrow may be a useful biomarker of systemic inflammation. Patients with Cushing syndrome demonstrate many metabolic changes involving muscles and fat tissue. Some mechanisms are known, but their relationship to glucose metabolism is not well investigated. Our study aimed to correlate ...